Hematologic Malignancy
Oncology·MeSH: Hematologic Neoplasms
10 drugs in development·7 companies·10 clinical trials
Drug Pipeline by Phase
Approved(2)
Phase 3(1)
| Drug | Company |
|---|---|
| pelabresib | Novartis AG (NVS) |
Phase 2(3)
Phase 1(3)
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| all-trans retinoic acid | Incyte Corp. (INCY) |
Compare drugs
Frequently asked questions
How many drugs are in development for Hematologic Malignancy?
BioSniper tracks 10 drugs in development for Hematologic Malignancy across 7 companies.
How many clinical trials target Hematologic Malignancy?
There are 10 clinical trials targeting Hematologic Malignancy tracked by BioSniper.
Deep-dive into Hematologic Malignancy
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis